Medigen Biotechnology Corp. (TPEX:3176)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.90
+0.05 (0.16%)
Apr 2, 2025, 1:30 PM CST

Medigen Biotechnology Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
4,4444,5146,2434,6857,9998,228
Upgrade
Market Cap Growth
-27.70%-27.70%33.24%-41.43%-2.78%-4.46%
Upgrade
Enterprise Value
6,3306,4708,4307,32810,27310,336
Upgrade
Last Close Price
31.9032.4044.8033.6057.4059.20
Upgrade
PS Ratio
3.243.295.394.442.0413.37
Upgrade
PB Ratio
2.810.901.250.721.251.83
Upgrade
P/TBV Ratio
3.053.054.202.253.524.96
Upgrade
P/FCF Ratio
---21.32-
Upgrade
P/OCF Ratio
119.03119.03--15.44-
Upgrade
EV/Sales Ratio
4.614.717.286.942.6216.79
Upgrade
EV/EBITDA Ratio
---10.62-
Upgrade
EV/EBIT Ratio
---13.17-
Upgrade
EV/FCF Ratio
-373.99---27.38-
Upgrade
Debt / Equity Ratio
0.200.200.570.430.150.26
Upgrade
Debt / EBITDA Ratio
----1.02-
Upgrade
Debt / FCF Ratio
----2.64-
Upgrade
Asset Turnover
0.180.180.130.120.550.11
Upgrade
Inventory Turnover
1.041.040.871.342.551.54
Upgrade
Quick Ratio
3.203.201.815.323.602.72
Upgrade
Current Ratio
3.963.962.056.404.623.24
Upgrade
Return on Equity (ROE)
-4.43%-4.43%-25.64%-29.95%19.60%-23.59%
Upgrade
Return on Assets (ROA)
-1.78%-1.78%-8.33%-11.46%6.79%-10.38%
Upgrade
Return on Capital (ROIC)
-1.95%-1.95%-9.01%-12.50%7.44%-11.36%
Upgrade
Return on Capital Employed (ROCE)
----10.90%-
Upgrade
Earnings Yield
-4.61%-4.54%-8.99%-14.42%-0.66%-4.11%
Upgrade
FCF Yield
-0.38%-0.38%-8.68%-27.46%4.69%-9.97%
Upgrade
Buyback Yield / Dilution
0.03%0.03%-0.16%-0.11%0.01%-0.22%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.